Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dependent propranolol effects on fear extinction and return of fear
2018-003409-25Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propranolol (3 arms), sponsored by KU Leuven. Primary endpoints: Conditioned fear response during extinction, Return of fear the next day off drug and 1 more. Started Oct 2018; status: completed.
02
Drugs
propranolol
Beyond the preview
Go deeper on 2018-003409-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003409-25.